latest news in Telehealth
Hims & Hers Scraps Compounded Weight Loss Pill Amid Regulatory Pressure
San Francisco, Monday, 9 February 2026.
Yielding to FDA pressure and legal threats, Hims & Hers retracted its $49 compounded weight-loss pill just 48 hours after launch, exposing the regulatory volatility of the lucrative off-brand GLP-1 market.